ICMR Will Get Royalty of 5% from Sale of Bharat Biotech’s Covaxin. Here’s Why It’s Raising Eyebrows

By
-
0
281

The intellectual property governing the use of Covaxin, jointly developed by Bharat Biotech and the ICMR, was “shared” and that is why it would receive royalty payments.